Clinical Trials Related to CSPC Pharmaceutical Group Limited

Related studies linked through entity extraction aliases.

Intraperitoneal Injection of Liposomal Irinotecan as Monotherapy or in Combination With Recombinant Mutant Human Tumor Necrosis Factor or Bevacizumab for the Treatment of Malignant Ascites Following Failure of Prior Standard Therapy

Status: RECRUITING
Phase: PHASE1/PHASE2

A Randomized Controlled Trial on the Efficacy and Safety of Butylphthalide in Reducing Myocardial Infarction Size and Improving Outcomes in STEMI Patients After Primary PCI

Status: NOT_YET_RECRUITING
Phase: PHASE3

Mitoxantrone Hydrochloride Liposome Injection-containing Bridging Regimen and CD19-targeting CAR-T Therapies

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2

Status: TERMINATED
Phase: PHASE1

VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

Status: RECRUITING
Phase: PHASE2

Efficacy and Safety of Preoperative Sintilimab Plus Nab-paclitaxel and Cisplatin in BR-ESCC Patients

Status: COMPLETED
Phase: PHASE2

Pegylated Liposomal Doxorubicin, PD-1 in Treating Muscle Invasive Bladder Cancer

Status: UNKNOWN
Phase: PHASE2